Citi Starts PTC Therapeutics (PTCT) at Buy
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $72.48 -0.55%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Join SI Premium – FREE
Citi initiated coverage on PTC Therapeutics (NASDAQ: PTCT) with a Buy rating and a price target of $81.00.
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $50.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Starts Weave Communications Inc (WEAV) at Buy
- Barclays Starts Enliven Therapeutics (ELVN) at Overweight
- Evercore ISI Starts (VMRK) at In Line
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
